Application of Yingtai Vacuum Centrifugal Concentrators in Oligonucleotide Synthesis
Vacuum centrifugal concentrators play a crucial role in oligonucleotide synthesis, serving as the essential bridge between chemical synthesis and purification.
1. Vacuum Centrifugal Concentration
Oligonucleotides are typically synthesized using the solid-phase phosphoramidite method, a multistep cyclic process involving reagent addition, chemical reactions, and washing steps. The final crude product is generally dissolved in a solution containing concentrated ammonium hydroxide, organic solvents (such as acetonitrile), and buffer salts.
Before downstream purification methods (such as HPLC, PAGE, or LC-MS) and subsequent applications including PCR, gene assembly, and nucleic acid therapeutic research, the crude product must undergo solvent removal and concentration for the following reasons:
Removal of ammonium hydroxide and deprotection by-products
Residual concentrated ammonium hydroxide can interfere with chromatographic purification and mass spectrometric analysis.
Removal of organic solvents
Residual acetonitrile and other organic solvents adversely affect chromatographic separation and reduce ionization efficiency in mass spectrometry, leading to signal suppression and distorted peak shapes.
Sample concentration
The crude synthesis solution typically has a volume of several milliliters and must be concentrated to microliter volumes to meet the injection requirements of purification systems such as HPLC, where injection loop volumes are generally between 50–500 μL.
Traditional concentration methods, including nitrogen blowdown and rotary evaporation, often suffer from limited throughput, sample loss caused by bumping, and thermal degradation of long oligonucleotides (>50-mer) due to elevated temperatures.
By combining centrifugal force, vacuum, and precisely controlled heating, vacuum centrifugal concentrators effectively overcome these limitations.
2. Advantages of Vacuum Centrifugal Concentration
The primary advantage of vacuum centrifugal concentrators in oligonucleotide synthesis is their ability to provide a gentle, efficient, and contamination-free transition from crude synthesis products to purification-ready samples.
Gentle Concentration
Under vacuum conditions, the boiling points of ammonium hydroxide and acetonitrile/water mixtures are significantly reduced, allowing rapid solvent evaporation at temperatures typically below 40°C. This low-temperature process protects heat-sensitive oligonucleotides—especially long sequences and those modified with fluorescent labels or phosphate groups—from thermal degradation.
High Throughput
The system is compatible with 96-well and 384-well plates as well as individual centrifuge tubes, enabling simultaneous processing of hundreds to thousands of samples in a single run and greatly increasing the throughput of oligonucleotide synthesis workflows.
Prevention of Cross-Contamination
During operation, centrifugal force keeps samples securely at the bottom of each tube or well, minimizing sample bumping. Meanwhile, solvent vapors are captured by a cold trap, effectively preventing aerosol formation and cross-contamination, thereby ensuring high sample integrity for downstream purification.
Broad Solvent Compatibility
Vacuum centrifugal concentrators efficiently process both aqueous and organic solvent systems, including mixtures containing acetonitrile, ammonium hydroxide, and water, making them highly versatile for oligonucleotide synthesis applications.
3. Typical Workflow
Following solid-phase oligonucleotide synthesis and ammonium hydroxide deprotection, the crude product solution containing the target oligonucleotide, ammonium hydroxide, and organic solvents is transferred into dedicated centrifuge tubes or 96-well plates compatible with the vacuum centrifugal concentrator.
The instrument then removes volatile components such as ammonium hydroxide and acetonitrile under vacuum with gentle heating (typically below 40°C), concentrating the sample to a microliter-scale volume.
The concentrated sample can subsequently be purified by HPLC or PAGE.
After purification, the collected fractions containing the target oligonucleotide are subjected to a second vacuum concentration step to remove the aqueous mobile phase completely, yielding either a dry oligonucleotide powder or a highly concentrated solution suitable for quantification, quality control, lyophilization, or downstream biological applications.
Step 1: Synthesis and Deprotection
Following solid-phase synthesis, ammonium hydroxide is used to cleave the oligonucleotide from the controlled pore glass (CPG) support while simultaneously removing nucleobase protecting groups.
Step 2: Primary Concentration
The crude product solution is placed into a vacuum centrifugal concentrator to remove the majority of ammonium hydroxide and organic solvents.
Step 3: Purification
The concentrated sample is purified using HPLC or PAGE to isolate the desired oligonucleotide.
Step 4: Secondary Concentration
The purified fractions are concentrated once again using the vacuum centrifugal concentrator to remove the mobile phase completely, producing either a dry oligonucleotide powder or a highly concentrated solution ready for lyophilization or direct downstream use.
This workflow enables efficient solvent removal while preserving oligonucleotide integrity, significantly improving purification efficiency, analytical performance, and overall productivity in oligonucleotide synthesis laboratories.
